167 related articles for article (PubMed ID: 9825395)
1. Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases.
Lazzeri M; Spinelli M; Beneforti P; Zanollo A; Turini D
Scand J Urol Nephrol; 1998 Sep; 32(5):331-4. PubMed ID: 9825395
[TBL] [Abstract][Full Text] [Related]
2. Intravesical vanilloids and neurogenic incontinence: ten years experience.
Lazzeri M; Spinelli M; Zanollo A; Turini D
Urol Int; 2004; 72(2):145-9. PubMed ID: 14963356
[TBL] [Abstract][Full Text] [Related]
3. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial.
Kim JH; Rivas DA; Shenot PJ; Green B; Kennelly M; Erickson JR; O'Leary M; Yoshimura N; Chancellor MB
J Spinal Cord Med; 2003; 26(4):358-63. PubMed ID: 14992337
[TBL] [Abstract][Full Text] [Related]
4. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study.
de Sèze M; Wiart L; de Sèze MP; Soyeur L; Dosque JP; Blajezewski S; Moore N; Brochet B; Mazaux JM; Barat M; Joseph PA
J Urol; 2004 Jan; 171(1):251-5. PubMed ID: 14665887
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders.
Cruz F
Int Urogynecol J Pelvic Floor Dysfunct; 1998; 9(4):214-20. PubMed ID: 9795827
[TBL] [Abstract][Full Text] [Related]
6. Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor.
Lazzeri M; Beneforti P; Turini D
J Urol; 1997 Dec; 158(6):2093-6. PubMed ID: 9366319
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of intravesical resiniferatoxin in treating detrusor hyper-reflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions.
Kuo HC
BJU Int; 2003 Oct; 92(6):597-601. PubMed ID: 14511042
[TBL] [Abstract][Full Text] [Related]
8. Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity.
Watanabe T; Yokoyama T; Sasaki K; Nozaki K; Ozawa H; Kumon H
Int J Urol; 2004 Apr; 11(4):200-5. PubMed ID: 15028097
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.
Kuo HC
J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711
[TBL] [Abstract][Full Text] [Related]
10. Intravesical capsaicin for treatment of detrusor hyperreflexia.
Fowler CJ; Beck RO; Gerrard S; Betts CD; Fowler CG
J Neurol Neurosurg Psychiatry; 1994 Feb; 57(2):169-73. PubMed ID: 8126498
[TBL] [Abstract][Full Text] [Related]
11. Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia.
Silva C; Rio ME; Cruz F
Eur Urol; 2000 Oct; 38(4):444-52. PubMed ID: 11025384
[TBL] [Abstract][Full Text] [Related]
12. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study.
Giannantoni A; Di Stasi SM; Stephen RL; Navarra P; Scivoletto G; Mearini E; Porena M
J Urol; 2002 Apr; 167(4):1710-4. PubMed ID: 11912393
[TBL] [Abstract][Full Text] [Related]
13. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M
J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
[TBL] [Abstract][Full Text] [Related]
14. Intravesical capsaicin in patients with detrusor hyper-reflexia--a placebo-controlled cross-over study.
Petersen T; Nielsen JB; Schrøder HD
Scand J Urol Nephrol; 1999 Apr; 33(2):104-10. PubMed ID: 10360450
[TBL] [Abstract][Full Text] [Related]
15. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions.
de Sèze M; Wiart L; Joseph PA; Dosque JP; Mazaux JM; Barat M
Neurourol Urodyn; 1998; 17(5):513-23. PubMed ID: 9776014
[TBL] [Abstract][Full Text] [Related]
16. Urodynamic assessment during intravesical infusion of capsaicin for the treatment of refractory detrusor hyperreflexia.
Lazzeri M; Spinelli M; Beneforti P; Zanollo A; Turini D
Spinal Cord; 1999 Jun; 37(6):440-3. PubMed ID: 10432264
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic options for refractory neurogenic detrusor overactivity.
Giannantoni A; Mearini E; Di Stasi SM; Costantini E; Zucchi A; Mearini L; Fornetti P; Del Zingaro M; Navarra P; Porena M
Minerva Urol Nefrol; 2004 Mar; 56(1):79-87. PubMed ID: 15195033
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.
Apostolidis A; Gonzales GE; Fowler CJ
Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519
[TBL] [Abstract][Full Text] [Related]
19. Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity.
Yokoyama T; Nozaki K; Fujita O; Nose H; Inoue M; Kumon H
J Urol; 2004 Aug; 172(2):596-600. PubMed ID: 15247740
[TBL] [Abstract][Full Text] [Related]
20. Effects of early intravesical administration of resiniferatoxin to spinal cord-injured rats in neurogenic detrusor overactivity.
Oliveira R; Coelho A; Franquinho F; Sousa MM; Cruz F; D Cruz C
Neurourol Urodyn; 2019 Aug; 38(6):1540-1550. PubMed ID: 31180583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
